| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Lucy J Troup, Robert D Torrence, Jeremy A Andrzejewski, Jacob T Braunwalde. Effects of cannabis use and subclinical depression on the P3 event-related potential in an emotion processing task. Medicine. vol 96. issue 12. 2017-04-12. PMID:28328830. |
the effects of residual cannabis use on emotional expression recognition and the p3 event-related potential in participants who scored highly for subclinical depression were investigated. |
2017-04-12 |
2023-08-13 |
human |
| Lucy J Troup, Robert D Torrence, Jeremy A Andrzejewski, Jacob T Braunwalde. Effects of cannabis use and subclinical depression on the P3 event-related potential in an emotion processing task. Medicine. vol 96. issue 12. 2017-04-12. PMID:28328830. |
residual cannabis use further reduced the p3 amplitude with the greatest deficits being associated with cannabis users who scored highly for subclinical depression. |
2017-04-12 |
2023-08-13 |
human |
| Alessandro Minarini, Silvia Ferrari, Martina Galletti, Nina Giambalvo, Daniela Perrone, Giulia Rioli, Gian Maria Galeazz. N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects. Expert opinion on drug metabolism & toxicology. vol 13. issue 3. 2017-02-27. PMID:27766914. |
promising results were found in trials testing the use of nac, mainly as an add-on treatment, in cannabis use disorder in young people, depression in bipolar disorder, negative symptoms in schizophrenia, and excoriation (skin-picking) disorder. |
2017-02-27 |
2023-08-13 |
Not clear |
| G Newton-Howes, J M Bode. Relation between age of first drinking and mental health and alcohol and drug disorders in adulthood: evidence from a 35-year cohort study. Addiction (Abingdon, England). vol 111. issue 4. 2017-01-30. PMID:26566814. |
to estimate associations between age of first drinking (afd) and alcohol use disorder, nicotine dependence, cannabis dependence, illicit drug dependence, major depression and anxiety disorder in adulthood, net of a series of covariate factors. |
2017-01-30 |
2023-08-13 |
Not clear |
| Gal Shoval, Liat Shbiro, Liron Hershkovitz, Noa Hazut, Gil Zalsman, Raphael Mechoulam, Aron Welle. Prohedonic Effect of Cannabidiol in a Rat Model of Depression. Neuropsychobiology. vol 73. issue 2. 2016-12-21. PMID:27010632. |
prohedonic effect of cannabidiol in a rat model of depression. |
2016-12-21 |
2023-08-13 |
rat |
| Raquel Linge, Laura Jiménez-Sánchez, Leticia Campa, Fuencisla Pilar-Cuéllar, Rebeca Vidal, Angel Pazos, Albert Adell, Álvaro Día. Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors. Neuropharmacology. vol 103. 2016-12-13. PMID:26711860. |
cannabidiol (cbd), the main non-psychotomimetic component of marihuana, exhibits anxiolytic-like properties in many behavioural tests, although its potential for treating major depression has been poorly explored. |
2016-12-13 |
2023-08-13 |
mouse |
| Heather Gilmou. Positive mental health and mental illness. Health reports. vol 25. issue 9. 2016-11-09. PMID:25229895. |
in accordance with the complete mental health model, mental health was also assessed in combination with the presence or absence of mental illness (depression; bipolar disorder; generalized anxiety disorder; alcohol, cannabis or other drug abuse or dependence). |
2016-11-09 |
2023-08-13 |
Not clear |
| Ethan Moitra, Bradley J Anderson, Michael D Stei. REDUCTIONS IN CANNABIS USE ARE ASSOCIATED WITH MOOD IMPROVEMENT IN FEMALE EMERGING ADULTS. Depression and anxiety. vol 33. issue 4. 2016-10-31. PMID:26636547. |
cannabis use and the development of depression symptoms have been linked in prospective research. |
2016-10-31 |
2023-08-13 |
Not clear |
| Ethan Moitra, Bradley J Anderson, Michael D Stei. REDUCTIONS IN CANNABIS USE ARE ASSOCIATED WITH MOOD IMPROVEMENT IN FEMALE EMERGING ADULTS. Depression and anxiety. vol 33. issue 4. 2016-10-31. PMID:26636547. |
however, no research has examined how depression symptoms might change relative to reductions in cannabis use. |
2016-10-31 |
2023-08-13 |
Not clear |
| Ethan Moitra, Bradley J Anderson, Michael D Stei. REDUCTIONS IN CANNABIS USE ARE ASSOCIATED WITH MOOD IMPROVEMENT IN FEMALE EMERGING ADULTS. Depression and anxiety. vol 33. issue 4. 2016-10-31. PMID:26636547. |
one group at risk for comorbid cannabis-use disorders and clinical depression is female emerging adults (those aged 18-25 years old) as cannabis use peaks during this period, depression is the most common psychiatric disorder among emerging adults, and females are at increased risk for depression relative to males. |
2016-10-31 |
2023-08-13 |
Not clear |
| Ethan Moitra, Bradley J Anderson, Michael D Stei. REDUCTIONS IN CANNABIS USE ARE ASSOCIATED WITH MOOD IMPROVEMENT IN FEMALE EMERGING ADULTS. Depression and anxiety. vol 33. issue 4. 2016-10-31. PMID:26636547. |
this study examined the longitudinal association between reductions in cannabis use and existing depression symptoms. |
2016-10-31 |
2023-08-13 |
Not clear |
| Susil Kulathilaka, Raveen Hanwella, Varuni A de Silv. Depressive disorder and grief following spontaneous abortion. BMC psychiatry. vol 16. 2016-10-19. PMID:27071969. |
abortion is associated with moderate to high risk of psychological problems such as depression, use of alcohol or marijuana, anxiety, depression and suicidal behaviours. |
2016-10-19 |
2023-08-13 |
Not clear |
| G Bersani, F S Bersani, E Caroti, P Russo, G Albano, G Valeriani, C Imperatori, A Minichino, G Manuali, O Corazz. Negative symptoms as key features of depression among cannabis users: a preliminary report. European review for medical and pharmacological sciences. vol 20. issue 3. 2016-10-13. PMID:26914132. |
negative symptoms as key features of depression among cannabis users: a preliminary report. |
2016-10-13 |
2023-08-13 |
Not clear |
| Anna-Karin Danielsson, Andreas Lundin, Emilie Agardh, Peter Allebeck, Yvonne Forsel. Cannabis use, depression and anxiety: A 3-year prospective population-based study. Journal of affective disorders. vol 193. 2016-09-29. PMID:26773900. |
cannabis use, depression and anxiety: a 3-year prospective population-based study. |
2016-09-29 |
2023-08-13 |
Not clear |
| Anna-Karin Danielsson, Andreas Lundin, Emilie Agardh, Peter Allebeck, Yvonne Forsel. Cannabis use, depression and anxiety: A 3-year prospective population-based study. Journal of affective disorders. vol 193. 2016-09-29. PMID:26773900. |
whether or not cannabis use may increase the risk for depression and/or anxiety is not clear. |
2016-09-29 |
2023-08-13 |
Not clear |
| Anna-Karin Danielsson, Andreas Lundin, Emilie Agardh, Peter Allebeck, Yvonne Forsel. Cannabis use, depression and anxiety: A 3-year prospective population-based study. Journal of affective disorders. vol 193. 2016-09-29. PMID:26773900. |
this study aimed at examining possible associations between cannabis use, depression and anxiety, using all three measures as both exposure and outcome. |
2016-09-29 |
2023-08-13 |
Not clear |
| Ashlee A Moore, Michael C Neale, Judy L Silberg, Brad Verhuls. Substance Use and Depression Symptomatology: Measurement Invariance of the Beck Depression Inventory (BDI-II) among Non-Users and Frequent-Users of Alcohol, Nicotine and Cannabis. PloS one. vol 11. issue 4. 2016-08-12. PMID:27046165. |
substance use and depression symptomatology: measurement invariance of the beck depression inventory (bdi-ii) among non-users and frequent-users of alcohol, nicotine and cannabis. |
2016-08-12 |
2023-08-13 |
Not clear |
| Sung-Wan Kim, Min Jhon, Jae-Min Kim, Stefan Smesny, Simon Rice, Michael Berk, Claudia M Klier, Patrick D McGorry, Miriam R Schäfer, G Paul Amminge. Relationship between Erythrocyte Fatty Acid Composition and Psychopathology in the Vienna Omega-3 Study. PloS one. vol 11. issue 3. 2016-07-29. PMID:26963912. |
partial correlation coefficients were calculated between baseline erythrocyte membrane fa levels, measured by gas chromatography, and scores on the positive and negative syndrome scale (panss), global assessment of functioning scale, and montgomery-asberg depression rating scale (madrs) after controlling for age, sex, smoking and cannabis use. |
2016-07-29 |
2023-08-13 |
human |
| Ethan Moitra, Paul P Christopher, Bradley J Anderson, Michael D Stei. Coping-motivated marijuana use correlates with DSM-5 cannabis use disorder and psychological distress among emerging adults. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors. vol 29. issue 3. 2016-05-25. PMID:25915689. |
after adjusting for other variables in the regression model, using mj to cope was positively associated with having dsm-5 cannabis use disorder (or = 1.85, 95% ci [1.31, 2.62], p < .01), mj problem severity (b = .41, 95% ci [.24, .57], p < .01), depression (b = .36, 95% ci [.23, .49], p < .01), and perceived stress (b = .37, 95% ci [.22, .51], p < .01). |
2016-05-25 |
2023-08-13 |
human |
| Victoria A Grunberg, Kismet A Cordova, L Cinnamon Bidwell, Tiffany A It. Can marijuana make it better? Prospective effects of marijuana and temperament on risk for anxiety and depression. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors. vol 29. issue 3. 2016-05-25. PMID:26415059. |
prospective effects of marijuana and temperament on risk for anxiety and depression. |
2016-05-25 |
2023-08-13 |
Not clear |